Theravance Biopharma shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theravance Biopharma by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.6M | 175k | 14.60 |
| 2025-06-30 | $624k | 57k | 11.03 |
| 2024-06-30 | $136k | 16k | 8.48 |
| 2022-03-31 | $387k | 41k | 9.56 |
| 2021-12-31 | $365k | 33k | 11.05 |
| 2021-09-30 | $327k | 44k | 7.39 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management